{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:40:57Z","timestamp":1773200457133,"version":"3.50.1"},"reference-count":68,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2023,6,16]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>Drug rediscovery refers to the principle of using \u2018old\u2019 drugs outside the indications mentioned in the summary of product characteristics. In the past decades, several drugs were rediscovered in a wide variety of medical fields. One of the most recent examples is the unconditional registration of thioguanine (TG), a thiopurine derivative, in patients with inflammatory bowel disease in the Netherlands. In this paper, we aim to visualise potential hurdles that hamper drug rediscovery in general, emphasise the global need for optimal use and development of potentially useful drugs, and provide an overview of the registration process for TG in the Netherlands. With this summary, we aim to guide drug rediscovery trajectories in the near future.<\/jats:p>","DOI":"10.1136\/gutjnl-2023-329679","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T13:20:50Z","timestamp":1687958450000},"page":"1985-1991","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Drug rediscovery in gastroenterology: from off-label to on-label use of thioguanine in inflammatory bowel disease"],"prefix":"10.1136","volume":"72","author":[{"given":"Nanne K H","family":"de Boer","sequence":"first","affiliation":[{"name":"Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands"},{"name":"Research Institute, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Noord-Holland, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melek","family":"Simsek","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands"},{"name":"School of Medicine, VU University, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4760-3269","authenticated-orcid":false,"given":"Berrie","family":"Meijer","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands"},{"name":"School of Medicine, VU University, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4344-1474","authenticated-orcid":false,"given":"Markus F","family":"Neurath","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ad","family":"van Bodegraven","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Geriatrics, Internal and Intensive Care Medicine (Co-MIK), Zuyderland Medical Centre, Heerlen-Sittard-Geleen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris J J","family":"Mulder","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"2025090715164407000_72.10.1985.1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.579"},{"key":"2025090715164407000_72.10.1985.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"2025090715164407000_72.10.1985.3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in crohn\u2019s disease","volume":"14","author":"Torres","year":"2020","journal-title":"Medical Treatment J Crohns Colitis"},{"key":"2025090715164407000_72.10.1985.4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2025090715164407000_72.10.1985.5","unstructured":"Zorginstituut Nederland. 2023 Available: www.medicijnkosten.nl"},{"key":"2025090715164407000_72.10.1985.6","unstructured":"WHO . WHO guideline on country pharmaceutical pricing policies. Second Edition. 2020."},{"key":"2025090715164407000_72.10.1985.7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11096-018-0646-4","article-title":"Off-label and unlicensed prescribing in Europe: implications for patients' informed consent and liability","volume":"40","author":"Aagaard","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"2025090715164407000_72.10.1985.8","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.9.1021"},{"key":"2025090715164407000_72.10.1985.9","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.161.3.282"},{"key":"2025090715164407000_72.10.1985.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2008.11.010"},{"key":"2025090715164407000_72.10.1985.11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamainternmed.2015.6058","article-title":"Association of off-label drug use and adverse drug events in an adult population","volume":"176","author":"Eguale","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2025090715164407000_72.10.1985.12","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/apt.15229","article-title":"Off-label prescriptions of drugs used for the treatment of crohn's disease or ulcerative colitis","volume":"49","author":"Simsek","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090715164407000_72.10.1985.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805143382001"},{"key":"2025090715164407000_72.10.1985.14","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170601074646"},{"key":"2025090715164407000_72.10.1985.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.05.001"},{"key":"2025090715164407000_72.10.1985.16","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.3748\/wjg.v12.i38.6115","article-title":"Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?","volume":"12","author":"van Bodegraven","year":"2006","journal-title":"World J Gastroenterol"},{"key":"2025090715164407000_72.10.1985.17","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.168"},{"key":"2025090715164407000_72.10.1985.18","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1468"},{"key":"2025090715164407000_72.10.1985.19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fonc.2017.00273","article-title":"Giving drugs a second chance: overcoming regulatory and financial hurdles in Repurposing approved drugs as cancer Therapeutics","volume":"7","author":"Hernandez","year":"2017","journal-title":"Front Oncol"},{"key":"2025090715164407000_72.10.1985.20","doi-asserted-by":"crossref","unstructured":"Venkatesan P . Pricing increases for cancer drugs sparks investigation. Lancet Oncol 2017;18. doi:10.1016\/S1470-2045(17)30408-4","DOI":"10.1016\/S1470-2045(17)30408-4"},{"key":"2025090715164407000_72.10.1985.21","unstructured":"Schrijen MAH . Excessive prices in the pharmaceutical sector. Is competition law the best remedy? Utrecht: Utrecht University, 2018."},{"key":"2025090715164407000_72.10.1985.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0338-x"},{"key":"2025090715164407000_72.10.1985.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11527-3"},{"key":"2025090715164407000_72.10.1985.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61696-1"},{"key":"2025090715164407000_72.10.1985.25","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt512"},{"key":"2025090715164407000_72.10.1985.26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40545-020-00249-9","article-title":"Unrealized potential of drug repositioning in Europe during COVID-19 and beyond: a physcian's perspective","volume":"13","author":"Bayoumy","year":"2020","journal-title":"J Pharm Policy Pract"},{"key":"2025090715164407000_72.10.1985.27","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.3748\/wjg.v22.i40.9012","article-title":"Efficacy of thioguanine treatment in inflammatory bowel disease: a systematic review","volume":"22","author":"Meijer","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2025090715164407000_72.10.1985.28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/apt.15280","article-title":"Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies","volume":"50","author":"Simsek","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090715164407000_72.10.1985.29","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/apt.17128","article-title":"Classic drugs in the time of new drugs: real-world, long-term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease","volume":"56","author":"Rezazadeh Ardabili","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090715164407000_72.10.1985.30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/17474124.2017.1294062","article-title":"Is there a role for thioguanine therapy in IBD in 2017 and beyond?","volume":"11","author":"Taylor","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2025090715164407000_72.10.1985.31","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/ecco-jcc\/jjac004","article-title":"The thiopurine tale: an unexpected journey","volume":"16","author":"Crouwel","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2025090715164407000_72.10.1985.32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bcpt.13530","article-title":"Population pharmacokinetics of azathioprine active metabolite in patients with inflammatory bowel disease and dosage regimens optimisation","volume":"128","author":"Lin","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2025090715164407000_72.10.1985.33","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.15.29"},{"key":"2025090715164407000_72.10.1985.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04905.x"},{"key":"2025090715164407000_72.10.1985.35","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/ibd\/izac195","article-title":"Rectally administrated thioguanine for distal ulcerative colitis: a multicenter case series","volume":"29","author":"Crouwel","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"2025090715164407000_72.10.1985.36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drudis.2018.09.001","article-title":"A well-tolerated and rapidly acting Thiopurine for IBD?","volume":"24","author":"Florin","year":"2019","journal-title":"Drug Discov Today"},{"key":"2025090715164407000_72.10.1985.37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200316432"},{"key":"2025090715164407000_72.10.1985.38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.10.4986"},{"key":"2025090715164407000_72.10.1985.39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.1.640"},{"key":"2025090715164407000_72.10.1985.40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006763","article-title":"Suppression of p21Rac signaling and increased innate immunity mediate remission in crohn's disease","volume":"6","author":"Parikh","year":"2014","journal-title":"Sci Transl Med"},{"key":"2025090715164407000_72.10.1985.41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80840"},{"key":"2025090715164407000_72.10.1985.42","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000122"},{"key":"2025090715164407000_72.10.1985.43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302527"},{"key":"2025090715164407000_72.10.1985.44","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3389\/fmicb.2018.00964","article-title":"Phagocytosis and epithelial cell invasion by Crohn's disease-associated adherent-invasive Escherichia Coli are inhibited by the anti-inflammatory drug 6-Mercaptopurine","volume":"9","author":"Migliore","year":"2018","journal-title":"Front Microbiol"},{"key":"2025090715164407000_72.10.1985.45","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/ibd\/izy047","article-title":"Methotrexate and thioguanine rescue therapy for conventional thiopurine failing ulcerative colitis patients: a multi-center database study on tolerability and effectiveness","volume":"24","author":"Meijer","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2025090715164407000_72.10.1985.46","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00938-7"},{"key":"2025090715164407000_72.10.1985.47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/00365521.2019.1629006","article-title":"Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients","volume":"54","author":"van Asseldonk","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"2025090715164407000_72.10.1985.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2007.10.013"},{"key":"2025090715164407000_72.10.1985.49","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/apt.17186","article-title":"Editorial: thiopurines in the multidrug era-time to rescue our memories over half a century of experience. authors' reply","volume":"56","author":"Rezazadeh Ardabili","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090715164407000_72.10.1985.50","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cgh.2018.05.009","article-title":"Clinical course of nodular regenerative hyperplasia in thiopurine treated inflammatory bowel disease patients","volume":"17","author":"Simsek","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090715164407000_72.10.1985.51","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000206"},{"key":"2025090715164407000_72.10.1985.52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904492"},{"key":"2025090715164407000_72.10.1985.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.06.020"},{"key":"2025090715164407000_72.10.1985.54","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13559"},{"key":"2025090715164407000_72.10.1985.55","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/ecco-jcc\/jjx181","article-title":"Thiopurines in inflammatory bowel disease: new findings and perspectives","volume":"12","author":"de Boer","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2025090715164407000_72.10.1985.56","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/apt.16050","article-title":"Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and\/or thiopurines in patients with inflammatory bowel disease","volume":"52","author":"Chupin","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090715164407000_72.10.1985.57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.16071"},{"key":"2025090715164407000_72.10.1985.58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.gastro.2018.11.039","article-title":"Thiopurine therapy in inflammatory bowel diseases: making new friends should not mean losing old ones","volume":"156","author":"de Boer","year":"2019","journal-title":"Gastroenterology"},{"key":"2025090715164407000_72.10.1985.59","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200108000-00001"},{"key":"2025090715164407000_72.10.1985.60","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(08)80058-3","article-title":"Idiosyncratic adverse reactions to 6-mercaptopurine (6-MP) and azathioprine (AZA) can be averted by switching to tioguanine (6-TG) in patients with IBD","volume":"120","author":"Dubinsky","year":"2001","journal-title":"Gastroenterology"},{"key":"2025090715164407000_72.10.1985.61","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1021\/ja01611a082","article-title":"The synthesis of 6-thioguanine","volume":"77","author":"Elion","year":"1955","journal-title":"J Am Chem Soc"},{"key":"2025090715164407000_72.10.1985.62","unstructured":"The Nobel prize in physiology or medicine 1988. Nobel Prize Outreach AB; 2023. Available: NobelPrize.org"},{"key":"2025090715164407000_72.10.1985.63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02583.x"},{"key":"2025090715164407000_72.10.1985.64","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1097\/MPG.0000000000003621","article-title":"Safety of thioguanine in pediatric inflammatory bowel disease: a multi-center case series","volume":"75","author":"Bayoumy","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025090715164407000_72.10.1985.65","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12876-020-01441-6","article-title":"Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom","volume":"20","author":"Bayoumy","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"2025090715164407000_72.10.1985.66","unstructured":"Langedijk J , Lisman J , Stolk P , et al . Rapport: Stimulering Van drug rediscovery. Naar Een Handelsvergunning Voor Nieuwe Toepassingen Van Bestaande Geneesmiddelen. 2023. Available: https:\/\/docplayer.nl\/2964559-Stimulering-van-drug-rediscovery.html"},{"key":"2025090715164407000_72.10.1985.67","unstructured":"Langedijk J . Continuous innovation in the drug life cycle. Thesis Utrecht University, 2016."},{"key":"2025090715164407000_72.10.1985.68","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ecco-jcc\/jjad013","article-title":"Thioguanine is effective as maintenance therapy for inflammatory bowel disease: a prospective multicentre registry study","volume":"17","author":"Simsek","year":"2023","journal-title":"J Crohns Colitis"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2023-329679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T22:17:02Z","timestamp":1757283422000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2023-329679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":68,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,9,13]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/gutjnl-2023-329679"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2023-329679","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]}}}